CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD)-Reference-Cited by-同舟云学术

CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD)

Published:2022-12 Issue: Volume:254 Page:141-148
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Kranendonk J^ORCID,Willems LH,Vijver-Coppen RJ. van der,Coenen M.,Adang E.,Donders R.,Zeebregts CJ,Deneer VHM,Reijnen MMPJ,Kramers C,Warlé MC

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference50 articles.

1. Update on peripheral artery disease: epidemiology and evidence-based facts;Shu;Atherosclerosis,2018

3. Richtlijnendatabase. Richtlijn perifeer arterieel vaatlijden 2016

4. Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS);Aboyans;Eur J Vasc Endovasc Surg,2018

5. Effectiveness of clopidogrel dose escalation to normalize active metabolite exposure and antiplatelet effects in CYP2C19 poor metabolizers;Horenstein;J Clin Pharmacol,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of CYP2C19 Genotype Status on Clinical Outcomes in Patients with Symptomatic Coronary Artery Disease, Stroke, and Peripheral Arterial Disease: A Systematic Review and Meta-Analysis;Drugs;2024-09-05

2. Current and future genomic applications for surgeons;The Annals of The Royal College of Surgeons of England;2024-04

3. Aiming for precision: CYP2C19 gene polymorphism and clopidogrel resistance in patients with peripheral artery disease;Thrombosis Research;2024-04

4. The effects of CYP2C19 genotype polymorphism and clopidogrel resistance on ischemic event occurrence in patients with peripheral arterial disease undergoing revascularization: A prospective cohort study;Thrombosis Research;2024-04

5. Cost-Effectiveness Analysis of Genotype-Guided Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention in Korea;Drug Targets and Therapeutics;2024-03-31